Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Ribeiro (SALVADOR/BA, Brazil). Clinical, inflammaory and functional analysis before, during and after treatment with Omalizumabe in patients with difficulty control asthma.. 4022

Member's Comments

No comment yet.

Related content which might interest you: Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study) Source: Eur Respir J , 49 (3) 1501885; DOI: 10.1183/13993003.01885-2015 Year: 2017 Managing asthma patients: which outcomes matter? Source: Eur Respir Rev 2008; 17: 53-61 Year: 2008 Clinical control, quality of life, physical activity levels, and psychosocial factors according to illness perception in subjects with asthma: a cluster analysis Source: Virtual Congress 2020 – Physical activity and chronic lung disease Year: 2020 What clinical features underlying GINA step 1-4 drive the level of treatment in patients with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 57s Year: 2001 Clinical, functional and laboratory assessment of treatment efficacy in COPD patients Source: International Congress 2014 – Predictors Year: 2014 A network analysis of clinical characteristics of patients with COPD: partial results. Source: International Congress 2018 – Chronic respiratory disease: effects of rehabilitation interventions in patients Year: 2018 Cluster analysis identifies distinct clinical phenotypes with poor treatment responsiveness in asthma. Source: International Congress 2018 – Asthma: clinical screening tools Year: 2018 Indacaterol/glycopyrronium (IND/GLY) improves lung function irrespective of gender baseline differences in patients with COPD: A pooled analysis from the IGNITE Program Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Asthma patients remain poorly controlled despite being prescribed maintenance treatment Source: Annual Congress 2005 - Allergic rhinitis and asthma in primary care Year: 2005 Early detection of asthma exacerbations by using action points in self-management plans Source: Eur Respir J 2013; 41: 53-59 Year: 2013 Budesonid/formoterol easyhaler: clinical efficiency and adherence to treatment in patients with partly controlled bronchial asthma (BA). Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 "It‘s like living with a time bomb"– European patients‘ perspective on severe asthma symptoms Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005 Relationship between asthma control test (ACT) and clinical, functional and inflammatory markers in treated and non treated asthmatics Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008 Symptom pattern and treatment for people non-compliant with asthma medication Source: Annual Congress 2005 - Allergic rhinitis and asthma in primary care Year: 2005 Which patients should be treated with anti-IgE? Source: Eur Respir Rev 2007; 16: 85-87 Year: 2007 Patients with persistent asthma may have poor disease control despite normal lung function: baseline data from a pan-European real-life study Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 Clinical effect of combined chemotherapy according to guidelines fro the treatment of pulmonary Mtcobacterium complex disease, including a follow-up study. Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 A new observer independent method to assess therapy response in children with severe asthma based on daily lung function Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 QAW039 (fevipiprant) improves lung function and control of asthma symptoms in patients with more severe air flow limitation: A proof-of-concept study Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Factors affecting patients’ decision to adjust treatment; secondary analysis of a randomised trial of treatment optimisation in patients with severe asthma Source: Virtual Congress 2021 – Asthma burden and management I Year: 2021